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Abstract
Objective:  To  estimate  the  prevalence  and  incidence  of  self-reported  diabetes  and  to  study  its
association  with  medium-  and  long-term  mortality  from  all  causes  in  persons  ≥65  years.
Design:  A  population-based  cohort  study  begun  in  1993.
Setting:  ‘‘Envejecer  en  Leganés’’  cohort  (Madrid).
Participants:  A  random  sample  of  persons  ≥65  years  (n  =  1277  in  the  1993  baseline  sample).
Methods:  Participants  were  classiﬁed  as  having  diabetes  if  they  so  reported  and  had  consulted
a physician  for  this  reason  within  the  last  year.  Diabetes  history  was  categorized  in  <10  and
≥10 years  in  1993.  Incidence  density  was  calculated  in  2-year  periods  in  non-diabetic  individ-
uals (1965  persons/2  years).  Vital  status  was  recorded  on  31  December  2011.  The  association
between  diabetes  history  ≥10  years  and  mortality  at  6  and  18  years  follow-up  was  studied  by
the Kaplan--Meier  and  Cox  regression  analyses  after  adjusting  for  age,  sex,  heart  disease  and
comorbidity.
Results: The  prevalence  of  self-reported  diabetes  rose  from  10.3%  in  1993  to  16.1%  in  1999
(p ≤  0.001)  and  was  higher  in  women  than  men  (p  ≤  0.05).  Total  incidence  density  was  2.6
cases/100 persons/2  years  (95%  CI:  2.0--3.3).  Medium-  and  long-term  mortality  was  higher  in
persons with  diabetes  history  ≥10  years  than  in  non-diabetic  individuals  (HR:  2.0;  95%  CI:
1.2--3.3 and  HR:  1.7;  95%  CI:  1.1--2.5,  respectively).  In  diabetics  with  history  <10  years  the
HR was  1.3  (95%  CI:  0.9--1.9)  and  HR:  1.5  (95%  CI:  1.2--1.9,  respectively).
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Conclusions:  Although  diabetes  is  clearly  associated  with  increased  risk  of  mortality,  it  is  sig-
niﬁcant only  for  patients  with  ≥10  years’  history  of  diabetes.
© 2013  Elsevier  Espan˜a,  S.L.U.  All  rights  reserved.
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Diabetes  en  personas  mayores:  prevalencia,  incidencia  y  su  asociación  con  la
mortalidad  general  a  medio  y  largo  plazo
Resumen
Objetivos:  Calcular  la  prevalencia  y  la  incidencia  de  diabetes  autorreferida  y  analizar  su  aso-
ciación con  la  mortalidad  general  a  medio  y  a  largo  plazo  en  personas  ≥  65  an˜os.
Disen˜o: Estudio  de  cohortes  de  base  poblacional  iniciado  en  1993.
Emplazamiento:  Cohorte  «Envejecer  en  Leganés» (Madrid).
Participantes:  Muestra  aleatoria  de  los  ≥  65  an˜os  (n  =  1.277  en  1993).
Mediciones  principales:  Diabético:  autorreferido  y  haber  visitado  al  médico  por  este  motivo  el
último an˜o.  Antigüedad  de  diabetes:  más  y  menos  de  10  an˜os  en  1993.  Prevalencia  en  1993,  1995,
1997 y  1999.  Densidad  de  incidencia  calculada  para  periodos  bianuales  (1.965  personas/2  an˜os).
Estado vital  registrado  a  31  de  diciembre  de  2011.  La  asociación  entre  diabetes  y  mortalidad
a 6  y  18  an˜os  se  estudió  mediante  Kaplan-Meier  y  regresión  de  Cox,  ajustando  por  edad,  sexo,
enfermedades  del  corazón  y  comorbilidad.
Resultados:  La  prevalencia  de  diabetes  autorreferida  aumentó  desde  el  10,3%  (1993)  hasta  el
16,1% (1999)  (p  ≤  0,001),  siendo  superior  en  mujeres  (p  ≤  0,05).  La  incidencia  de  diabetes  fue
de 2,66  casos  por  100  personas/2  an˜os  (IC  95%:  1,9-3,3).  La  mortalidad  a  medio  y  a  largo  plazo
fue mayor  en  diabéticos  con  ≥  10  an˜os  que  en  no  diabéticos  (HR:  2,0;  IC  95%:  1,2-3,3,  y  HR:
1,7; IC  95%:  1,1-2,5,  respectivamente).  En  diabéticos  <  10  an˜os  el  HR  para  mortalidad  fue  1,3
(IC 95%:  0,9-1,9)  y  1,5  (IC  95%:  1,2-1,9),  respectivamente.
Conclusiones:  Aunque  padecer  diabetes  se  asocia  a  un  aumento  de  la  mortalidad,  esta  aso-
ciación es  signiﬁcativa  solo  para  los  pacientes  con  historia  de  diabetes  igual  o  superior  a
10 an˜os.
©  2013  Elsevier  Espan˜a,  S.L.U.  Todos  los  derechos  reservados.
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MIntroduction
Over  the  past  20  years,  there  has  been  an  explosive  increase
in  the  number  of  cases  of  diabetes  mellitus  in  both  devel-
oped  and  developing  countries.1 The  International  Diabetes
Federation  (IDF)  has  recently  estimated  that  in  2030,  9.9%
of  the  adult  population  worldwide  will  have  diabetes  (552
million).2 Diabetes  mellitus  prevalence  rates  are  rising.  The
prevalence  of  diagnosed  diabetes  among  US  adults  aged
18  years  and  over  increased  from  5.1%  in  1997  to  9.2%
in  2010,3 and  the  number  of  individuals  in  the  US  with  a
new  diagnosis  of  diabetes  is  expected  to  increase  in  the
next  decades,  with  the  fastest  increase  occurring  in  older
and  minority  subpopulations.4 In  Europe,  the  prevalence  of
diabetes  varies  among  studies.5 The  reasons  for  this  are
multiple,  and  include  the  different  methodologies  used.6
The  prevalence  of  diabetes  in  the  adult  population  of  Spain
(aged  18  years  and  over)  ranges  from  6%  to  12%  based  on
self-reported  data,7 and  from  20%  to  25%  with  measured
data.8
Not  only  the  prevalence  of  diabetes,  but  also  its  inci-
dence  is  rising  at  an  alarming  rate.  This  increase  is  likely  to
have  a  signiﬁcant  public  health  impact  given  the  high  rates
of  acute  myocardial  infarction,  heart  failure,  stroke,  and
death  that  follow  diabetes,1 and  implies  a  substantial  bur-
den  on  both  the  individual  and  the  healthcare  system.9 Yet
little  research  has  been  conducted  on  diabetes  in  elderly
S
T
nopulations.  In  addition,  because  diabetes  is  a  silent  dis-
ase,  with  no  sudden  or  exact  date  of  onset,  it  is  difﬁcult  to
esign  studies  of  disease  incidence.10
Lastly,  mortality  is  known  to  be  higher  in  people
ith  diabetes  than  in  those  without  it,11 and  diabetes
ccounts  for  considerable  morbidity  and  mortality  in  the
lderly  population.9,12 However,  again,  little  information  is
vailable  about  how  diabetes  affects  mortality  when  the
iagnosis  is  made  at  an  older  age.13
The  longitudinal  study  ‘‘Aging  in  Leganés’’14 offers  an
pportunity  to  examine  in  greater  depth  the  magnitude  of
iabetes  and  its  association  with  all-cause  mortality  in  a
uropean  Mediterranean  population  of  people  aged  65  years
nd  over,  an  age  group  for  which  few  data  are  available.
hus,  the  aims  of  this  study  are  to  estimate  (1)  the  preva-
ence  and  incidence  of  diabetes  and  (2)  the  association
etween  diabetes  and  medium-  and  long-term  mortality  in
 population-based  cohort  of  people  aged  65  years  or  older
n  Spain.
ethodstudy  subjects
his  study  used  data  from  the  population-based  longitudi-
al  study  ‘‘Aging  in  Leganés’’  which  began  in  1993.  The
3m
d
i
p
(
l
r
p
1
(
m
d
a
p
m
M
I
i
a
t
c
V
H
q
w
s
w
t
t
m
t
t
a
I
t
t
l
a
m
t
b
f
a
w
y
v
a
c
v
j
p
t
b
S
D
u
L
a
s
p
c
a
o
K
t
m
a
y
b
l
o
t
t
v
1
s
b
d
1
K
s
g
3
o
m
t
t
I
t
v
y
o
w
f78  
ethodological  characteristics  of  this  study  have  been
escribed  elsewhere.14,15 In  brief,  Leganés  is  a  city  located
n  a  metropolitan  area  8  km  from  Madrid  (Spain).  The  census
opulation  in  1991  was  171,400  inhabitants,  of  whom  13,679
8%)  were  over  64  years  of  age.  ‘‘Aging  in  Leganés’’  was
aunched  in  1993,  starting  with  a  gender-  and  age-stratiﬁed
andom  sample  obtained  from  the  Leganés  census  of  the
opulation  aged  65  years  and  over.  In  the  baseline  cohort
283  persons  completed  the  study.
Data  were  collected  using  a  standardized  questionnaire
a  face-to-face  home  interview)  that  included  sociode-
ographic  variables,  health  status  and  history  of  chronic
iseases.14,15
The  present  study  uses  data  from  the  1993  baseline,
s  well  as  the  1995,  1997  and  1999  waves  to  know  the
revalence  and  incidence  of  diabetes  and  the  sociode-
ographic  and  clinical  variables  selected  for  this  study.
ortality  at  31/12/2011  was  obtained  from  National  Death
ndex.
All  individuals  with  available  diabetes  data  were  included
n  the  analysis  (1277  at  baseline,  939  in  1995,  743  in  1997
nd  519  in  1999)  (see  Flow  chart  for  the  study).
The  local  ethics  committee  approved  the  protocol  for
he  Leganés  study,  and  all  participants  signed  an  informed
onsent  form.
ariables  and  procedures
istory  of  diabetes  was  collected  by  self-reporting  using  two
uestions  to  the  participants  at  baseline  and  in  follow-up
aves:  ‘‘Do  you  have  diabetes?’’  and  ‘‘Did  you  have  ever
een  a  physician  in  the  last  year  for  this  problem?’’  People
ho  answered  ‘‘yes’’  to  both  the  questions  were  considered
o  have  diabetes  and  were  asked  to  state  the  year  when
hey  became  aware  of  their  condition.  Diabetes  history  was
easured  in  years  of  diabetes  at  the  time  of  incorporation  of
he  individual  in  the  baseline  cohort  (1993)  and  classiﬁed  in
hree  categories:  no  diabetes,  less  than  10  years  of  diabetes
nd  10  or  more  years  of  diabetes.
Mortality  data  were  obtained  from  the  National  Death
ndex  (NDI),  a  computerized  database  with  information  on
he  vital  status  of  all  residents  in  Spain.  To  compensate  for
he  delay  in  updating  mortality  in  the  NDI,  data  were  col-
ected  until  June  2012.  The  cut-off  date  for  the  mortality
nalysis  was  31/12/1999  (n  =  330;  25.8%)  for  medium-term
ortality  (6  years)  and  31/12/2011  (n  =  994;  77.8%)  for  long-
erm  mortality  (18  years).
Age  (years),  sex,  body  mass  index,  heart  disease,  comor-
idity,  self-rated  health  and  years  of  diabetes,  obtained
rom  the  1993  baseline  Leganés  questionnaire,  were  used
s  co-variables  in  the  analysis.
Body  Mass  Index  (BMI)  in  kg/m2 based  on  measures  of
eight  and  height.
Self-rated  health  (response  to  the  question:  ‘‘How  wouldou  describe  your  health  at  present?’’:  fair,  poor  or  very  poor
ersus  good  or  very  good).
Heart  disease  includes  angina,  myocardial  infarction
nd/or  heart  failure.
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Comorbidity  was  deﬁned  as  having  4  or  more  chronic
onditions  of  a  list  of  9  (heart  disease,  stroke,  peripheral
ascular  disease  (PVD),  chronic  respiratory  disease  (CRD),
oint  or  bone  pain,  cancer,  Parkinson’s,  genital  or  urinary
athology  and  gastrointestinal  pathology).  Chronic  condi-
ions  were  assessed  by  self-report  of  having  been  diagnosed
y  a  medical  doctor.
tatistical  analysis
ue  to  the  sampling  design,  prevalence  and  incidence  ﬁg-
res  are  weighted  using  the  age  and  sex  distribution  of  the
eganés  population  in  1995.  The  data  were  weighted  by
ssigning  a  speciﬁc  weight  (W)  to  each  individual  in  the
ample,  calculated  as  W  =  N1/N:n1/n  where  N  is  the  total
opulation  in  Leganés,  and  n  is  the  number  of  people  in  the
ohort;  N1 and  n1 are  the  respective  numbers  in  each  age
nd  sex  group.
Fort  the  study  of  continuous  variables,  the  goodness
f  ﬁt  to  the  normal  distribution  was  analyzed  using  the
olmogorov--Smirnov  test;  all  cases  ﬁt  the  Gaussian  curve,
herefore  the  continuous  variables  were  expressed  as
eans  ±  standard  deviation,  and  categorical  variables  as
bsolute  and  relative  frequencies  (n  and  %).  A  bivariate  anal-
sis  was  made  for  sex  with  distribution  of  variables  in  the
aseline  using  2 test.  The  prevalence  of  diabetes  was  calcu-
ated  by  age  group  (65--74  and  ≥75  years)  and  sex  for  each
f  the  four  waves  (1993,  1995,  1997  and  1999).  To  study
he  change  in  the  prevalence  of  diabetes  over  time,  the  2
endency  test  was  used.
For  the  calculation  of  incidence,  all  non-diabetic  indi-
iduals  in  the  previous  waves  were  used:  978  persons  in
995,  783  in  1997,  and  566  in  1999.  The  incidence  den-
ity  (incident  cases/person-time  periods)  was  calculated  for
iannual  periods  and  expressed  as  the  number  of  cases  of
iabetes  per  100  persons  by  2-year  time  periods.  In  total,
965  persons/time  periods  were  used.
Mortality  analyses  were  conducted  with  the
aplan--Meier  analysis  and  adjusted  by  the  Cox  regres-
ions.  To  evaluate  the  association  between  diabetes  and
eneral  mortality,  Cox  regression  was  used  at  two  moments:
1/12/1999  (6  years  of  follow-up)  and  31/12/2011  (18  years
f  follow-up).  Median  survival  was  calculated,  and  the
ain  results  were  summarized  with  hazard  ratios  (HRs)  and
heir  95%  CIs.  Person  follow-up  time  was  calculated  from
he  time  people  were  incorporated  into  the  study  in  1993.
ndividuals  were  censored  if  they  died  or  dropped  out  of
he  study.
Diabetes,  as  a  principal  variable,  was  used  as  a  dummy
ariable  (ﬁctitious  variable):  (0)  no  diabetes,  (1)  less  than  10
ears  of  diabetes  at  baseline  (1993),  and  (2)  10  or  more  years
f  diabetes  at  baseline  (1993).  Four  multivariate  Cox  models
ere  built:  (1)  crude  diabetes  data,  (2)  diabetes  adjusted
or  age  and  sex,  (3)  additionally  adjusted  for  heart  dis-
ase  and  (4)  additionally  adjusted  for  comorbidity.  Results
ith  p  less  than  0.05  were  considered  statistically  signiﬁ-
ant.  SPSS  version  19.0  and  Epidat  3.1  were  used  for  the
nalysis.
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Results
Characteristics  of  the  study  subjects
Of  the  1283  participating  individuals  in  the  baseline  cohort
(1993),  diabetes  self-reported  data  were  available  in  1277
individuals  who  participated  in  this  wave,  of  which  50.4%
were  men  and  49.6%  were  women.  The  ﬂow  chart  for  the
study  shows  the  number  of  participants  in  each  of  the  waves,
as  well  as  the  number  of  those  who  died  or  were  lost  to
follow-up  in  each  wave.  The  distribution  of  the  variables
studied  in  the  baseline  cohort  is  presented  in  Table  1.  Women
had  a  higher  body  mass  index  than  men,  as  well  as  poorer
self-rated  health,  a  higher  frequency  and  longer  history  of
diabetes,  and  more  comorbidity  (p  ≤  0.001).
I
T
(revalence  of  diabetes
he  prevalence  of  diabetes  in  the  study  population
weighted  data)  increased  progressively  over  time,  from
0.3%  (95%  CI:  8.6--11.9)  in  1993  to  16.1%  in  1999  (95%  CI:
3.2--18.9),  p ≤  0.001.  In  the  1993  and  1995  waves,  women
ad  a  signiﬁcantly  higher  prevalence  than  men  (p  ≤  0.05)
Table  2).
The  mean  duration  of  diabetes  in  the  142  participants
ho  had  the  disease  at  study  baseline  (1993)  was  7.8  years
SD  ±  6.8;  range  0--30  years).ncidence  of  diabetes
he  total  biannual  incidence  density  of  diabetes  was  2.6
95%  CI:  1.9--3.3)  cases  per  100  persons  at  2  years  of
380  M.  Sánchez  Martínez  et  al.
Table  1  Distribution  of  variables  in  the  baseline  Leganés  cohort  (1993).
Variables Men  (n  =  644)  Women  (n  =  633)  Total  (n  =  1277)
Age  [mean  (SD)]  75.6  (8.1)  75.9  (8.1)  75.8  (8.1)
Body mass  index  (BMI)  [mean  (SD)]  26.3  (3.4)  28.0  (4.8)*** 27.1  (4.2)
Self-rated health  fair,  poor  or  very  poor  [n  (%)]  357  (55.4)  432  (68.2)*** 789  (61.8)
Diabetic patients  [n  (%)]  47  (7.3)  75  (11.8)** 122  (9.6)
Patients with  10  or  more  years  history  of  diabetes  [n  (%)] 5  (0.8) 28  (4.4)*** 33  (2.6)
Heart disease  [n  (%)] 163  (25.3) 139  (22.0) 302  (23.6)
Comorbidity (≥4  diseases)  [n  (%)] 285  (44.3) 388  (61.3)*** 673  (52.7)
** p ≤ 0.05.
*** p ≤ 0.001.
Table  2  Age-speciﬁc  prevalence  of  diagnosed  diabetes  by  sex  from  1993  to  1999.a
1993  (n  =  1277)  1995  (n  =  939)  1997  (n  =  743)  1999  (n  =  519)  Tendency-p
% [95%  CI]  %  [95%  CI]  %  [95%  CI]  %  [95%  CI]
Total  10.3  [8.6--11.9]  11.7  [9.7--13.6]  14.5  [12.1--16.9]  16.1  [13.2--18.9]  ≤0.001
Men 7.6  [5.4--9.8]  9.2  [6.4--11.9]  12.5  [9.1--15.9]  15.6  [11.2--19.9]  ≤0.001
Women 12.3** [9.9--14.6]  13.6** [10.8--16.4]  16.1  [12.7--19.4]  16.4  [12.5--20.3]  ≤0.005
Age (years)
65--74  (total)  10.1  [8.0--12.2]  11.6  [9.0--14.2]  14.0  [10.6--17.3]  15.5  [10.9--20.0]  ≤0.005
Men 8.1  [5.3--10.9]  9.6  [6.1--13.2]  12.4  [7.7--17.1]  15.8  [9.2--22.4]  ≤0.05
Women 11.8* [8.7--14.8]  13.4  [9.5--17.2]  15.5  [10.4--20.5]  15.2  [8.7--21.6]  0.148
≥75 (total)  10.6  [7.9--13.2]  12.2  [9.1--15.3]  14.8  [11.5--18.2]  16.7  [12.9--20.5]  ≤0.005
Men 6.5  [2.8--10.2]  8.9  [4.5--13.4]  12.7  [7.6--17.8]  15.5  [9.5--21.5]  ≤0.002
Women 12.9  [9.2--16.7]  14.2* [10.0--18.4]  16.2  [11.7--20.8]  17.5  [12.5--22.5]  0.126
a Weighted data.
** p ≤ 0.05.
* p ≤ 0.10.
follow-up,  2.8  (95%  CI:  1.7--3.8)  in  men  and  2.5  (95%
CI:  1.6--3.4)  in  women.  In  general,  the  incidence  den-
sity  of  diabetes  decreased  with  increasing  age,  although
this  difference  was  not  statistically  signiﬁcant.  Differ-
ences  between  sexes  were  not  statistically  signiﬁcant
(Table  3).
Table  3  Age-speciﬁc  biannual  incidence  of  diagnosed  dia-
betes  by  sex  (per  100  population)  from  1993  to  1999.a
Percentage  95%  conﬁdence
interval
Total  2.6  2.0--3.3
Men 2.8  1.7--3.8
Women  2.5  1.6--3.4
Age (groups),  years
65--74  3.2  2.3--4.2
Men 3.3  1.9--4.8
Women  3.1  1.8--4.4
≥75 1.7  0.8--2.6
Men 1.7 0.2--3.2
Women  1.6  0.5--2.8
a Weighted data.
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ur  data  show  that  survival  time  for  older  persons  with  10
r  more  years  history  of  diabetes  is  2.7  years  less  than  for
on-diabetic  individuals.  The  Kaplan--Meier  medians  in  the
edium-term  models  did  not  reach  statistical  signiﬁcance.
edian  survival  in  the  long  term  was  10.8  years  (95%  CI:
0.1--11.5)  for  non-diabetic  persons;  9.0  (95%  CI:  6.8--11.1)
or  persons  with  less  than  10  years’  history  of  diabetes  from
aseline  (1993);  and  8.1  years  (95%  CI:  5.5--10.6)  for  those
ith  10  or  more  years’  history  of  diabetes  from  baseline
1993).
As  can  be  seen  in  Table  4,  the  hazard  ratio  for  medium-
nd  long-term  mortality  in  persons  with  10  or  more  years’
istory  of  diabetes  was  2.0  (95%  CI:  1.2--3.3)  and  1.7  (95%
I:  1.1--2.5),  respectively,  after  adjusting  for  age  and  sex,
eart  disease  and  comorbidity.  Accordingly,  it  can  be  said
hat  medium-term  mortality  is  twice  as  high  in  persons  with
0  or  more  years’  history  of  diabetes  at  baseline  than  in
on-diabetic  individuals,  and  is  70%  higher  in  the  long  term.
The  hazard  ratio  for  medium-  and  long-term  mortality
n  diabetic  individuals  with  less  than  10  years’  history  of
iabetes  at  baseline  was  1.3  (95%  CI:  0.9--1.9)  and  1.5  (95%
I:  1.2--1.9),  respectively.  Thus,  it  can  be  said  that  in  the
edium  term  (6  years),  those  with  less  than  10  years’  history
t  baseline  do  not  have  higher  mortality  than  non-diabetic
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Table  4  Association  of  diabetes  with  all-cause  mortality  (Cox  regression  Hazard  Model).a
Medium-term  mortality
(1993--1999)
Long-term  mortality
(1993--2011)
HR  95%  CI  p-Value  HR  95%  CI  p-Value
Crude  dataa
Less  than  10  years  of  diabetes  in  1993  1.2  0.8--1.6  0.394  1.4  1.1--1.7  0.007
10 or  more  years  of  diabetes  in  1993  1.6  1.0--2.7  0.051  1.4  0.9--2.0  0.096
Adjusted for  age  and  sexa
Less  than  10  years  of  diabetes  in  1993 1.4 1.0--2.0 0.056 1.6  1.3--2.0  <0.001
10 or  more  years  of  diabetes  in  1993 2.1 1.3--3.5 0.003 1.8 1.2--2.6 0.003
Additionally  adjusted  for  heart  diseasea
Less  than  10  years  of  diabetes  in  1993  1.3  0.9--1.9  0.095  1.6  1.2--2.0  <0.001
10 or  more  years  of  diabetes  in  1993  2.0  1.2--3.4  0.006  1.7  1.2--2.6  0.005
Additionally adjusted  for  comorbiditya
Less  than  10  years  of  diabetes  in  1993 1.3 0.9--1.9  0.141  1.5  1.2--1.9  0.001
10 or  more  years  of  diabetes  in  1993 2.0 1.2--3.3  0.009  1.7  1.1--2.5  0.009
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persons,  whereas  their  long-term  mortality  is  almost  50%
higher  (Fig.  1).
Discussion
Although  increasing  age  is  a  risk  factor  for  the  development
of  diabetes  and  its  vascular  complications,  few  studies  have
focused  speciﬁcally  on  the  impact  of  diabetes  in  elderly
populations.9,12,16 In  our  study,  the  prevalence  of  diabetes  in
individuals  aged  65  years  and  over  increased  from  10.3%  in
1993  to  16.1%  in  1999.  These  data  are  consistent  with  other
population  studies:  a  Canadian  study  found  that  diabetes
increased  from  10.6%  to  17.1%  after  10  years  of  follow-up  in
a  population  over  age  50,17 while  a  US  study  reported  that
the  prevalence  of  diabetes  increased  from  12.5%  to  17.7%  in
individuals  aged  65  and  over  during  18  years  of  follow-up.18
In  the  DECODE  study  (Diabetes  Epidemiology:  Collabo-
rative  analysis  of  Diagnostic  criteria  in  Europe),19 which
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Figure  1  Medium-  and  long-term  survival  of  diabetic  patients  and
and comorbidity.aseline (1993).
easured  plasma  glucose  in  13  European  cohorts,  in  accor-
ance  with  WHO  recommendations  for  the  diagnosis  of
iabetes,  the  prevalence  of  diabetes  was  10--20%  in  indi-
iduals  aged  60--79  years.  In  a  recent  study,20 conducted
n  subjects  aged  >60  years  in  Spain  and  with  characteris-
ics  similar  to  ours,  the  overall  prevalence  of  diabetes  was
6.8%,  slightly  higher  than  ours  (13.1%).  This  variation  may
e  related  to  the  methodology  used  to  collect  the  infor-
ation  as  well  as  the  variability  of  results  when  they  are
elf-reported  by  the  patient.  In  a  study  in  people  older  than
5  years  in  the  United  States  using  data  from  Medicare,  the
revalence  increased  from  15.3%  at  baseline  to  24.8%  after
 years  of  follow-up.12
In  general,  the  prevalence  of  diabetes  in  the  same  age
roups  was  much  higher  in  1999  than  in  the  previous  waves.
lso  in  accordance  with  other  studies17,21 we  found  that
ost  cases  of  diabetes  occurred  in  the  oldest  individuals.
ne  possible  explanation  for  this  could  be  a  progressively
reater  awareness  of  diabetes  on  the  part  of  both  patients
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nd  medical  professionals.  Although  most  studies  in  the
eneral  population  have  found  a  higher  prevalence  of  dia-
etes  in  men,6,20,22 some  have  found  that  the  prevalence
n  people  over  age  65  is  higher  in  women.23 The  DECODE
tudy  has  reported  diabetes  prevalence  rates  of  8.5%  in
en  and  9.3%  in  women  between  the  ages  of  60  and  69
ears,  increasing  to  12.4%  in  men  and  15.4%  in  women
etween  age  70  and  79  years,  and  to  12.9%  in  men  and
2.4%  in  women  between  age  80  and  89.19 Our  results  are
onsistent  with  the  aforementioned  studies.  The  prevalence
n  1993  was  7.6%  in  men  and  12.3%  in  women,  rising  to
.2%  and  13.6%  respectively,  in  1995.  The  differences  by
ex  found  in  1997  and  1999  are  not  statistically  signiﬁ-
ant.
ncidence  of  diabetes
ecause  diabetes  has  a  silent  course,  without  a  sudden  or
xact  date  of  onset,  it  is  difﬁcult  to  design  studies  of  disease
ncidence.10
In  Spain,  the  few  studies  that  have  estimated  the  inci-
ence  of  diabetes  are  not  consistent  because  they  did  not
ollow  a  standardized  methodology.24 Moreover,  most  previ-
us  studies  in  Spain  have  provided  diabetes  incidence  data
n  people  under  age  65  years,  and  therefore  are  not  compa-
able  with  our  data.10,25 A  recent  study  in  Spain  in  persons
ged  18--65  years25 found  an  annual  diabetes  incidence  of
9.1  cases  per  1000  person-years,  slightly  higher  than  that
n  our  study.  However,  the  annual  incidence  of  diabetes
n  European  studies  conducted  in  the  general  population
aries  between  1.2  and  4.1  cases/1000  people,26,27 which
s  lower  than  the  ﬁgures  published  for  the  Spanish  popula-
ion.
Our  results  for  diabetes  incidence  in  persons  aged  65
ears  and  over  show  an  incidence  rate  equivalent  to  13.1
ases  per  1000  person-years  (2.6  cases  per  100  persons-
 years  of  follow-up),  which  is  between  the  24  per  1000
erson-years  reported  in  a  study  made  in  US  elderly12 and
.4  cases  per  1000  person-years  for  the  population  65  years
nd  over  in  Spain.28 In  these  two  studies  the  incidence
ates  increased  with  increasing  age.  In  our  study  the  inci-
ence  is  higher  in  the  65--74  years  age  group  [3.2  (95%  CI:
.3--4.2)]  than  in  those  aged  75  years  and  over  [1.7  (95%  CI:
.8--2.6)].
ortality  associated  with  diabetes
iabetes  has  been  associated  with  an  average  10  years  of
ife  lost  for  individuals  diagnosed  during  middle  age.29 Indi-
iduals  with  diabetes  have  an  excess  mortality  compared
ith  people  without  diabetes. 11 However,  it  is  not  clear
ow  diabetes  affects  mortality  when  the  diagnosis  is  made
t  an  older  age.13 Our  data  show  that  the  survival  time  for
eople  in  the  older  population  with  10  or  more  years  his-
ory  of  diabetes  is  2.7  years  less  than  that  for  non-diabetic
ndividuals.
Mortality  in  the  medium  term  for  persons  with  10
r  more  years  history  of  diabetes  is  almost  double  that
f  people  without  diabetes,  while  long-term  mortality  is
lmost  70%  higher.  Those  with  less  than  10  years  history
f  diabetes  at  baseline  do  not  have  higher  mortality  than
n
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on-diabetic  individuals  in  the  medium  term,  but  long-
erm  mortality  is  almost  50%  higher.  In  a  systematic  review
f  observational  studies11 reporting  mortality  in  patients
ver  age  60  diagnosed  with  type  2  diabetes,  those  with
iabetes  were  found  to  have  40%  higher  mortality  than
on-diabetic  persons,  which  is  lower  than  found  in  our
tudy.
Thus,  our  results  show  a  clear  association  between  dia-
etes  and  increased  all-cause  mortality,  although  this  effect
s  statistically  signiﬁcant  only  in  patients  who  have  had  dia-
etes  for  at  least  10  years.
trengths  and  limitations
he  main  strength  of  our  study  is  the  long  follow-up  time
18  years).  Added  to  this  is  the  fact  that,  to  date,  few  stud-
es  of  diabetes  incidence  and  mortality  have  been  made  in
editerranean  populations.
One  of  the  limitations  of  this  study  is  that  we  used
elf-reported  data  to  assess  diabetes.  Several  authors  point
ut  that  self-reported  data  could  underestimate  diabetes
revalence.10,12,20 Although  this  underestimation  is  possible,
ther  authors  have  conﬁrmed  that  self-reported  diabetes  is  a
easonably  reliable  surrogate  for  diagnosed  diabetes,  based
n  their  studies  of  the  accuracy  of  patients’  self-reports
ompared  with  medical  records.30,31
In  health  care  systems  where  general  practitioners
ave  a  complete  vision  of  their  patients’  medical  sta-
us  and  in  which  patients  have  easy  and  frequent  access
o  medical  services,  patients  are  more  likely  to  be  well
nformed  about  their  diseases,  especially  in  the  case  of
hronic  diseases  like  diabetes.  This  is  the  case  in  Spain,32
here  every  community-dwelling  person  is  registered  in
he  patient  list  of  a  general  practice,  and  access  to
ther  health  care  facilities,  including  outpatient  clinics,
s  only  possible  through  referral  by  a  general  practi-
ioner.
Furthermore,  in  our  study,  individuals  were  classiﬁed
s  having  diabetes  not  only  based  on  their  awareness  of
heir  condition,  but  also  because  they  had  seen  a  physi-
ian  in  the  last  year  for  this  problem.  The  second  question
n  medical  consultations  in  the  last  year  increases  the
alidity  of  the  self-report.  In  1993  people  in  our  sample
veraged  8.3  consultations  with  general  practitioners,  simi-
ar  to  the  current  rate  of  general  practitioner  consultations
n  Spain.33
Our  sample  was  drawn  from  a  metropolitan  area  of
adrid,  therefore  this  study  may  not  be  comparable  to  other
on-Mediterranean  population  studies  and  cannot  strictly  be
eneralized  to  the  whole  older  Spanish  population.
Together  with  Sherwin  R  and  Jastreboff  AM,34 we  can
ay  that  ‘‘today’s  message  is  that  a diabetes  tsunami  is
mminent,  and  the  only  way  to  minimize  the  damage  is
o  create  an  early  warning  system  and  improve  interven-
ions  to  protect  those  in  its  path’’.  Effective  public  health
nterventions  to  prevent  diabetes  are  needed,  together  with
he  resources  required  to  manage  the  increasingly  large
umber  of  people  who  are  living  longer  with  this  debili-
ating  disease.17 In  accordance  with  Rose,  we  think  that
he  ‘‘population  strategy’’  with  regard  to  prevention  should
lways  be  the  discovery  and  control  of  the  causes  of  the
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incidence  of  chronic  diseases.35 In  the  case  of  diabetes,
important  factors  for  prevention  could  be  reducing  obesity,
increasing  physical  activity  and  maintaining  a  Mediterranean
diet.
What is known about the topic
•  Diabetes  mellitus  is  a  chronic  disease  with  major
impact  on  health,  and  its  prevalence  and  incidence
are  increasing.
• Because  diabetes  is  a  silent  disease,  with  no  sudden
or  exact  date  of  onset,  it  is  difﬁcult  to  design  studies
of  disease  incidence.
•  It  is  known  that  mortality  is  higher  in  diabetics
than  in  non-diabetics,  and  diabetes  in  the  elderly  is
responsible  for  a  signiﬁcant  morbidity  and  mortality.
What brings the study
•  The  article  analyzes  the  prevalence  of  self-reported
diabetes  in  Spain  in  a  base  population  cohort  of  peo-
ple  over  65  years  (Aging  in  Leganes  cohort).
The  prevalence  of  diabetes  increased  progres-
sively  over  time,  from  10.3%  in  1993  to  16.1%  in  1999.
Women  had  a  signiﬁcantly  higher  prevalence  than
men.
•  The  diabetes  incidence  in  this  population  during
the  study  period  (1993--1999)  was  13.1  cases  per
1000  person-years  (2.6  cases  per  100  persons/2  years
of  follow-up).  No  differences  were  found  between
sexes  neither  between  the  age  group  65--74  years
and  people  over  75  years.
•  Although  diabetes  is  clearly  associated  with
increased  risk  of  mortality,  it  is  signiﬁcant  only
for  patients  with  ≥10  years  history  of  diabetes.
Mortality  for  persons  with  10  or  more  years  of
history  of  diabetes  is  almost  70%  higher  than  people
without  diabetes.
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